Supplementary Figure 6 from Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients

PDF file - 101K, Full-length immunoblots of ERK1/2 activation before and after TPA treatment in Kasumi-1 cells and ERK1/2 activation before and after TPA and EPO treatment in normal BMMC. Original graphic indicating a correlation between the EPO response in vitro and in vivo